Increased circulating M2-like monocytes in patients with breast cancer

M2-like tumor-associated macrophages promote breast tumor growth and survival and may migrate into the peripheral blood. However, the frequency of circulating M2-like monocytes in the peripheral blood of breast cancer patients has not been clarified. The objective of this study was to determine the...

Full description

Saved in:
Bibliographic Details
Main Authors: Boke Zhang, Manlin Cao, Yiqing He, Yiwen Liu, Guoliang Zhang, Cuixia Yang, Yan Du, Jing Xu, Jiajie Hu, Feng Gao
Format: Article
Language:English
Published: SAGE Publishing 2017-06-01
Series:Tumor Biology
Online Access:https://doi.org/10.1177/1010428317711571
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849397209613729792
author Boke Zhang
Manlin Cao
Yiqing He
Yiwen Liu
Guoliang Zhang
Cuixia Yang
Yan Du
Jing Xu
Jiajie Hu
Feng Gao
author_facet Boke Zhang
Manlin Cao
Yiqing He
Yiwen Liu
Guoliang Zhang
Cuixia Yang
Yan Du
Jing Xu
Jiajie Hu
Feng Gao
author_sort Boke Zhang
collection DOAJ
description M2-like tumor-associated macrophages promote breast tumor growth and survival and may migrate into the peripheral blood. However, the frequency of circulating M2-like monocytes in the peripheral blood of breast cancer patients has not been clarified. The objective of this study was to determine the percentages of circulating M2-like monocytes in patients with breast cancer. Immunofluorescence staining for CD68 and CD163 was performed to detect M2-like macrophages in pathological tissues. Flow cytometry was used to assess the frequencies of circulating CD14 + CD163 + /CD14 + CD204 + /CD14 + CD163 + CD204 + M2-like monocytes in 99 breast cancer patients, 56 patients with benign breast disease, and 60 healthy controls. Receiver operating characteristic curve analysis was used to compare the diagnostic values of circulating M2-like monocytes, carcinoembryonic antigen, and cancer antigen 15-3. The associations among circulating M2-like monocytes and clinical breast cancer parameters were analyzed. The number of CD68 + CD163 + M2-like macrophages was significantly higher in breast cancer tissues than in benign tissues. In the peripheral blood, CD14 + CD163 + /CD14 + CD204 + /CD14 + CD163 + CD204 + M2-like monocytes were elevated in breast cancer patients compared with normal controls and patients with benign breast disease. The area under the receiver operating curve for circulating CD14 + CD163 + CD204 + M2-like monocytes was 0.888 (95% confidence interval: 0.839–0.936), a value higher than those for carcinoembryonic antigen and cancer antigen 15-3. High frequencies of circulating CD14 + CD204 + and CD14 + CD163 + CD204 + M2-like monocytes were associated with tumor–node–metastasis stage, lymph node metastasis, histological differentiation, and estrogen receptor expression. Circulating M2-like monocytes may serve as a diagnostic biomarker in breast cancer and have a potential role in reflecting breast cancer progression.
format Article
id doaj-art-c27e30642e114727863cb96368fdbacd
institution Kabale University
issn 1423-0380
language English
publishDate 2017-06-01
publisher SAGE Publishing
record_format Article
series Tumor Biology
spelling doaj-art-c27e30642e114727863cb96368fdbacd2025-08-20T03:39:05ZengSAGE PublishingTumor Biology1423-03802017-06-013910.1177/1010428317711571Increased circulating M2-like monocytes in patients with breast cancerBoke Zhang0Manlin Cao1Yiqing He2Yiwen Liu3Guoliang Zhang4Cuixia Yang5Yan Du6Jing Xu7Jiajie Hu8Feng Gao9Department of Molecular Biology, Shanghai Jiao Tong University Affiliated Sixth People’s Hospital, Shanghai, P.R. ChinaDepartment of Rehabilitation Medicine, Shanghai Jiao Tong University Affiliated Sixth People’s Hospital, Shanghai, P.R. ChinaDepartment of Molecular Biology, Shanghai Jiao Tong University Affiliated Sixth People’s Hospital, Shanghai, P.R. ChinaDepartment of Molecular Biology, Shanghai Jiao Tong University Affiliated Sixth People’s Hospital, Shanghai, P.R. ChinaDepartment of Molecular Biology, Shanghai Jiao Tong University Affiliated Sixth People’s Hospital, Shanghai, P.R. ChinaDepartment of Molecular Biology, Shanghai Jiao Tong University Affiliated Sixth People’s Hospital, Shanghai, P.R. ChinaDepartment of Molecular Biology, Shanghai Jiao Tong University Affiliated Sixth People’s Hospital, Shanghai, P.R. ChinaDepartment of Clinical Laboratory, Shanghai Jiao Tong University Affiliated Sixth People’s Hospital, Shanghai, P.R. ChinaDepartment of Molecular Biology, Shanghai Jiao Tong University Affiliated Sixth People’s Hospital, Shanghai, P.R. ChinaDepartment of Clinical Laboratory, Shanghai Jiao Tong University Affiliated Sixth People’s Hospital, Shanghai, P.R. ChinaM2-like tumor-associated macrophages promote breast tumor growth and survival and may migrate into the peripheral blood. However, the frequency of circulating M2-like monocytes in the peripheral blood of breast cancer patients has not been clarified. The objective of this study was to determine the percentages of circulating M2-like monocytes in patients with breast cancer. Immunofluorescence staining for CD68 and CD163 was performed to detect M2-like macrophages in pathological tissues. Flow cytometry was used to assess the frequencies of circulating CD14 + CD163 + /CD14 + CD204 + /CD14 + CD163 + CD204 + M2-like monocytes in 99 breast cancer patients, 56 patients with benign breast disease, and 60 healthy controls. Receiver operating characteristic curve analysis was used to compare the diagnostic values of circulating M2-like monocytes, carcinoembryonic antigen, and cancer antigen 15-3. The associations among circulating M2-like monocytes and clinical breast cancer parameters were analyzed. The number of CD68 + CD163 + M2-like macrophages was significantly higher in breast cancer tissues than in benign tissues. In the peripheral blood, CD14 + CD163 + /CD14 + CD204 + /CD14 + CD163 + CD204 + M2-like monocytes were elevated in breast cancer patients compared with normal controls and patients with benign breast disease. The area under the receiver operating curve for circulating CD14 + CD163 + CD204 + M2-like monocytes was 0.888 (95% confidence interval: 0.839–0.936), a value higher than those for carcinoembryonic antigen and cancer antigen 15-3. High frequencies of circulating CD14 + CD204 + and CD14 + CD163 + CD204 + M2-like monocytes were associated with tumor–node–metastasis stage, lymph node metastasis, histological differentiation, and estrogen receptor expression. Circulating M2-like monocytes may serve as a diagnostic biomarker in breast cancer and have a potential role in reflecting breast cancer progression.https://doi.org/10.1177/1010428317711571
spellingShingle Boke Zhang
Manlin Cao
Yiqing He
Yiwen Liu
Guoliang Zhang
Cuixia Yang
Yan Du
Jing Xu
Jiajie Hu
Feng Gao
Increased circulating M2-like monocytes in patients with breast cancer
Tumor Biology
title Increased circulating M2-like monocytes in patients with breast cancer
title_full Increased circulating M2-like monocytes in patients with breast cancer
title_fullStr Increased circulating M2-like monocytes in patients with breast cancer
title_full_unstemmed Increased circulating M2-like monocytes in patients with breast cancer
title_short Increased circulating M2-like monocytes in patients with breast cancer
title_sort increased circulating m2 like monocytes in patients with breast cancer
url https://doi.org/10.1177/1010428317711571
work_keys_str_mv AT bokezhang increasedcirculatingm2likemonocytesinpatientswithbreastcancer
AT manlincao increasedcirculatingm2likemonocytesinpatientswithbreastcancer
AT yiqinghe increasedcirculatingm2likemonocytesinpatientswithbreastcancer
AT yiwenliu increasedcirculatingm2likemonocytesinpatientswithbreastcancer
AT guoliangzhang increasedcirculatingm2likemonocytesinpatientswithbreastcancer
AT cuixiayang increasedcirculatingm2likemonocytesinpatientswithbreastcancer
AT yandu increasedcirculatingm2likemonocytesinpatientswithbreastcancer
AT jingxu increasedcirculatingm2likemonocytesinpatientswithbreastcancer
AT jiajiehu increasedcirculatingm2likemonocytesinpatientswithbreastcancer
AT fenggao increasedcirculatingm2likemonocytesinpatientswithbreastcancer